AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06323564 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Self-report questionnaires in AN
Description: STAI Y2 (20 items trait anxiety), TEIque (153 items), STAI Y1 (20 items state anxiety), DFlex (24 items), ERQ (10 items), EISR (33 items), BDI (21 items), TAS-20 (20 items), WLEIS (16 ITEMS), CFI (20 ITEMS), CCFQ (18 items).
Study NCT06323564 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Analysis of bio-humoral parameters
Description: the analysis of bio-humoral parameters (interleukin 6, cortisol, serotonin, catecholamines and endorphins) will be also performed through morning venous blood sampling at T0, at half of the rehabilitation process and at T1
Study NCT05066321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Oriented Recovery Enhancement Sessions
Description: The MORE intervention will involve 8 weekly sessions (approximately 1 hour each), during which participants will be taught how to use mindfulness skills to regulate addiction severity, pain, and stress.
Study NCT03271814 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: LPS
Description: 0.6 by/kg LPS single dose iv
Study NCT03271814 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LPS
Description: 0.6 by/kg LPS single dose iv
Study NCT03271814 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sterile Water
Study NCT06388850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Relationships Project
Description: The Healthy Relationships Project (HRP), created by the community-based organization Prevent Child Abuse Vermont (PCAVT), will be the focus of this rigorous evaluation study. The program is fully manualized with a widely accepted curriculum designed for Pre-K to 2nd graders (Care for Kids) and 3rd to 6th graders (We Care Elementary, though implementation will stop at 5th grade for this study). The HRP uses an upstream universal public health approach for the primary prevention of child and youth perpetration of child sexual abuse with developmentally appropriate intervention elements for children, faculty and staff at their schools, and for their caregivers.
Study NCT06256315 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hyper-ERAS Program
Description: Patients who met the inclusion criteria were treated with Hype-ERAS protocol, including preoperative education, intraoperative quality control, postoperative preventive analgesia, early ambulation, early recovery of diet, early removal of the drainage tube, urinary catheter, and gastric tube, and discharge within 48 hours or more than 48 hours safter surgery, and closely and standardized follow-up outside the hospital.
Study NCT05604495 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Sweat Test
Description: In people with cystic fibrosis (CF), there is a problem in the transport of chloride across cell membranes. This results in higher concentrations of chloride (as salt) in sweat compared to those who do not have cystic fibrosis. So, if there is a family history or a possibility of CF, the sweat test is part of the special tests to help make, or exclude, a diagnosis of cystic fibrosis.
Study NCT05069064 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: music
Description: In the music group, music that chosen by the participant will be played through a speaker by the nursing staff during outpatient hysteroscopy. Music will be played through a speaker instead of headphone in order to maintain a good communication and interaction between the participant and the doctor.
Study NCT05069064 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: no music
Description: Participants in the non-music group will undergo hysterosalpingography in the same setting and standard procedure without listening to any music.
Study NCT05546164 — intervention group
Intervention type: OTHER
Intervention: Assessment of hand grip strength
Description: Assessment of hand grip strength
Study NCT05546164 — intervention group
Intervention type: OTHER
Intervention: Assessment of pinch strength
Description: Assessment of pinch strength
Study NCT05546164 — intervention group
Intervention type: OTHER
Intervention: Assessment of upper limb dexterity
Description: Assessment of upper limb dexterity
Study NCT04167748 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (PGT-A)
Description: 24-chromosome screening for aneuploidy in the preimplantation embryo (blastocyst stage)
Study NCT06491056 — intervention group
Intervention type: DEVICE
Intervention: Focal Therapy for Prostate Cancer
Description: Ablation of \<75% of the prostate gland for limited volume prostate cancer
Study NCT06473311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: whole bady vibration and virtual reality
Description: study group I received a whole body vibration program in addition to a conventional physical therapy program, and study group II received a Wii-fit therapy program (a virtual reality treatment program) in addition to the same. A two-month treatment program was implemented for both groups. Every child in both groups had the same evaluation processes, which included using the Physical Self Maintenance Scale (PSMS) for daily living activities and a dynamometer to measure quadriceps muscular strength. Evaluation was done prior to the start of treatment and was done again after one month (post I) and two months (post II).
Study NCT05988268 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vibration Foam Rolling
Description: The vibration foam rolling method will be applied to the gluteal, tensor fascia latae, hamstring, quadriceps femoris, and gastrocnemius muscles of both lower extremities of the participants in the Vibration Foam Rolling Group, in addition to the routine warm-up protocol, 3 days a week for a total of 15 minutes a day for 6 weeks.
Study NCT05988268 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-Vibration Foam Rolling
Description: The non-vibration foam rolling method will be applied to the gluteal, tensor fascia latae, hamstring, quadriceps femoris, and gastrocnemius muscles of both lower extremities of the participants in the Non-Vibration Foam Rolling Group, in addition to the routine warm-up protocol, 3 days a week for a total of 15 minutes a day for 6 weeks.
Study NCT05863975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human interferon alpha 2b vaginal Effervescent capsules
Description: ①Interferon group: human interferon alpha 2b vaginal effervescent capsule vaginal medication. ② Promestriene group: promestriene cream vaginal medication. ③Interferon + promestriene combination group: two drugs were given in combination.
Study NCT05539729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: A marketed antibiotic (Study Drug) supplied by Amerisource Bergen, by the Mount Sinai Investigational Drug Services (IDS), and encapsulated in red coating to match the placebo.
Study NCT05539729 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo created by the IDS and encapsulated in red coating to match the Study Drug.
Study NCT06237543 — intervention group
Intervention type: OTHER
Intervention: hypotension
Description: MAP below 55 mmHg or long-term (2 minutes or more) hypotensive attacks will be treated with ephedrine 0.1mg/kg.
Study NCT04450667 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nutricia PreOp
Description: Oral rehydration 2 hours before the scheduled cesarean section under spinal anesthesia
Study NCT04811404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethyl Eicosapentaenoic Acid
Description: Treatment will be for six weeks
Study NCT06317818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stem Cells
Description: Suspension of mesenchymal stromal cells for intratissular injection
Study NCT06317818 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Comparative placebo
Description: Cell-free cell suspension solution devoid of cells for intratissular injection
Study NCT06317675 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Osteopathic manipulative treatment (OMT)
Description: Manual therapy on different area of the body.
Study NCT06317675 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Description: Manual therapy on different area of the body.
Study NCT06024395 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dental FearLess
Description: Dental FearLess is a self-administered CBT-based mobile app that takes approximately 1 hour to complete.
Study NCT06091085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Description: Administered for 3 nights, half-dose (1 pill) on the first night followed by full dose (2x250mg pills) for 2 nights
Study NCT06091085 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo sugar pills administered for 3 nights, half-dose (1 pill) on the first night followed by full dose (2 pills) for 2 nights
Study NCT04896047 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Meal test and muscle biopsies
Description: The FGF19 parameters will be assessed in fasting and in postprandial period after the consumption of a hyper-carbohydrate and hyper-lipidic test meal called Flexmeal.~A muscle biopsies by a needle will be performed before and after the Flexmeal.
Study NCT04896047 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Meal test and muscle biopsies
Description: The FGF19 parameters will be assessed in fasting and in postprandial period after the consumption of a hyper-carbohydrate and hyper-lipidic test meal called Flexmeal.~A muscle biopsies by a needle will be performed before and after the Flexmeal.
Study NCT06387654 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sampling
Description: Blood will be taken in larger quantity
Study NCT06387654 — intervention group
Intervention type: BIOLOGICAL
Intervention: Remainders of samples taken as part of the treatment
Description: blood, CSF, saliva, stools, urine, other biological fluids and tissue biopsies, hair follicles
Study NCT04328246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IES System
Description: The IES system is composed of a stimulator and self-adhesive surface gel electrodes.
Study NCT04328246 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care Therapy
Description: Standard institutional practices for treating pressure injury.
Study NCT04328246 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Therapy
Description: Standard institutional practices for treating pressure injury.
Study NCT05963958 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Description: Brain stimulation using active high definition transcranial direct current stimulation is applied simultaneously with the use of dexmedetomidine as a pharmacological treatment for delirium in critical illness patients with covid-19
Study NCT05963958 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Sham HD-tDCS
Description: Sham high definition transcranial direct current stimulation is applied simultaneously with the use of dexmedetomidine as a pharmacological treatment for delirium in critical illness patients with covid-19
Study NCT05003947 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study NCT06654583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactive Play Mat
Description: Use of developed interactive play mat that utilizes haptic feedback vibrations to assist children with delayed milestones in achieving Gross Motor Skills. The play mat aims to provide a therapeutic and engaging experience by incorporating visuals, sounds, and lights to encourage movement that might otherwise be challenging for these children.
Study NCT06654583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy
Description: Stretching and Strengthening exercises
Study NCT06595212 — intervention group
Intervention type: OTHER
Intervention: multiomic profile to assess genetic and environmental risk factiors
Description: Genomic, epigenetic, proteomic, microbiome, immunology, biomarker, metabolite, pesticide, metal, and metalloid investigations will be conducted. The twins will be followed longitudinally from a clinical perspective, with biological sample collections to assess discordance and identify early disease signatures in unaffected individuals.
Study NCT04785170 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amino Acid
Description: A novel non-protein amino acid secreted by skeletal muscles which aids the cross-talk between skeletal muscles, liver, and adipose tissue at molecular levels. amino acid is generated by catabolism of the branched-chain amino acid valine. Existing literature states, amino acid induces body fat loss by increasing energy expenditure, stimulating free fatty acid (FFA) oxidation in the liver and skeletal muscle cell, and by enhancing oxygen consumption by adipose tissue and hepatocytes. It was observed that amino acid stimulated differentiation of energy storing white adipose tissue preadipocytes to an energy burning beige (brown to white) phenotype.
Study NCT05244291 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch
Description: Therapeutic Touch will be applied to infants for 3 consecutive days, once a day, 10 minutes at any time during the day. There will be a four-day break. The Therapeutic Touch will be done a total of 3 times a week or 6 times in 2 weeks.
Study NCT04858763 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: There will be no intervention during this study.
Study NCT06275763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phase C: Eplerenone
Description: Participants randomly assigned to this arm take Eplerenone and placebos of Spironolactone and Torasemide
Study NCT06275763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phase C: Spironolactone
Description: Participants randomly assigned to this arm take Spironolactone and placebos of Eplerenone and Torasemide
Study NCT06275763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phase C: Torasemide
Description: Participants randomly assigned to this arm take Torasemide and placebos of Eplerenone and Spironolactone
Study NCT06275763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phase B: Triplixam / Elestar HCT
Description: Replacement of ineffective antihypertensive treatment based on 3 or more antihypertensive drugs (single or dual drug preparations) with a triple single pill combination (SPC) based on optimally combined antihypertensive drugs: perindopril + indapamide + amlodipine (P+I+A) or olmesartan + hydrocholothiazide + amlodipine (O+H+A).
Study NCT06275763 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phase B: Triplixam / Elestar HCT
Description: Replacement of ineffective antihypertensive treatment based on 3 or more antihypertensive drugs (single or dual drug preparations) with a triple single pill combination (SPC) based on optimally combined antihypertensive drugs: perindopril + indapamide + amlodipine (P+I+A) or olmesartan + hydrocholothiazide + amlodipine (O+H+A).
Study NCT06275763 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Phase A: Confirmation of uncontrolled hypertension
Description: Confirmation of the true ineffectiveness of antihypertensive therapy based on 3 or more antihypertensive drugs (single or dual drug preparations) using ABPM and home BP measurements.
Study NCT05627414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin
Description: 2.5mg/kg，IV，Q3W
Study NCT05627414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200 mg，IV，Q3W
Study NCT05627414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-1
Description: 40\~60mg / m2, bid, d1-14, repeated every 3 weeks.
Study NCT05627414 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy with paclitaxel
Description: Paclitaxel (PTX) was used with a dose of 60mg / m2, Q3W. （Only for patients with peritoneal metastases）
Study NCT05479253 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Artificial intelligence assistant system
Description: The artificial intelligence assistant system can automatically capture images, prompt abnormal lesions and the parts covered by the examination (the stomach is divided into 26 parts).
Study NCT05113160 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conversation Treatment for Aphasia
Description: Conversation treatment is a theoretically motivated approach in which a speech language pathologist facilitates discourse about topics of interest to the client using individualized, multi-modal supports. Treatment occurs either in groups of 6-8 people with aphasia or 2 people with aphasia. Individual communication goals are targeted for each group member within the context of naturalistic conversations.
Study NCT04244630 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: Antioxidants
Description: Over-the-counter anti-oxidants, namely vitamin E, NAc cysteine, L-cystine, Nicotinamide and Taurursodiol at defined doses
Study NCT05494021 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-process management software
Description: Enrolled participants will managed by a pre-designed software. The software would provide helpful assistance, such as lung cancer education, decision-making, assisting in making and attending LCS LDCT appointments, arranging follow-up when needed, tobacco cessation support for smokers, treatment assistance if diagnosed as lung cancer.
Study NCT05494021 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LDCT detection
Description: LDCT were performed in both arm. The abnormal nodules were defined as noncalcified nodules (NCN) larger than 5 mm
Study NCT05494021 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LDCT detection
Description: LDCT were performed in both arm. The abnormal nodules were defined as noncalcified nodules (NCN) larger than 5 mm
Study NCT06038240 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Savoring Meditation
Description: Participants will learn about pain neuroscience and will learn/practice a positive emotion generative practice (Savoring Meditation).
Study NCT06038240 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pain Self-Management and Education
Description: Participants will learn about the biopsychosocial drivers of chronic pain.
Study NCT04824820 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vibrator
Description: Clitoral stimulation
Study NCT06273007 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PartoMa intervention(Locally achievable intrapartum care guideline), in house LDHF trainings
Description: We will implement PartoMa interventions: seminars, LDHF training, and supportive supervision
Study NCT05207995 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous tolerogenic dendritic cells
Description: Autologous tolerogenic dendritic cells treated with Vitamin-D3, co-cultivated with mesenchymal stem cell and primed peptides (MSC-tolDC) injected subcutaneous.
Study NCT05207995 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment according to the clinical protocols
Description: Standard treatment of type 1 diabetes mellitus according to the clinical protocols
Study NCT05207995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard treatment according to the clinical protocols
Description: Standard treatment of type 1 diabetes mellitus according to the clinical protocols
Study NCT05496179 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prucalopride
Description: Prokinetic
Study NCT05496179 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metoclopramide
Description: Prokinetic
Study NCT06654609 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Insoles for Foot
Description: Assess the condition of foot ulcers in patients, beginning with creating a cast of the affected foot. After the initial rectification, necessary modifications are made to prepare the rough insole. The size and fit of the insole are then carefully checked against the patient's foot. I use local silicone materials, secured with lady socks or stockinette to ensure the insole stays in place and provides durability.
Study NCT06654206 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Supervised strength exercise sessions: There will be two sessions per week, each lasting 50 minutes. Each session will consist of three distinct parts:~Warm-up: 10 minutes of global strength and aerobic exercises at 60% of estimated VO2max, focusing on the areas that will primarily be worked on during that session.~Strength training: 6 strength exercises targeting the major muscle groups, lasting 30 minutes. The initial load will be set between 40-70% of the estimated 1-RM (assessed in the first session and based on the individual patient). When the participant is able to complete 3 sets of 12 repetitions with the established weight in two consecutive sessions, the weight will be increased by 10%. The exercises will be performed in a circuit format with 30 seconds of rest between exercises and 90 seconds of rest between sets.~Cool-down/stretching: 10 minutes of a combination of breathing exercises and stretching for the major muscle groups.~Promotion of physical activity: Participants